Corporate Governance

Oasmia Pharmaceutical AB (publ) is a public limited liability company listed on NASDAQ Stockholm and the Frankfurt Stock Exchange and is governed by a number of laws and regulations. The most important of these are the Swedish Companies Act, the Swedish Annual Accounts Act, NASDAQ Stockholm’s Rule Book for Issuers and the Swedish Corporate Governance Code.

Management, guidance and internal control are divided between the shareholders (via the Annual General Meeting), the Board of Directors, the CEO and corporate management. Oasmia also works in accordance with the internal instructions and guidelines adopted by Oasmia’s Board and management team. In addition, Oasmia’s auditors are responsible for the external control of the company.

  Report
2019 Corporate Governance report 2018/2019
2018 Corporate governance report 2017/2018
2017 Corporate governance report 2016/2017
2016 Corporate governance report 2015/2016
2015 Corporate governance report 2014/2015
2014 Corporate governance report 2013/2014
2013 Corporate governance report 2012/2013
2012 Corporate governance report 2011/2012
2011 Corporate governance report 2010/2011
2010 Corporate governance report 2009/2010